Background:
To investigate auditory and vestibular functions, estrogen levels, and its clinical correlation in postmenopausal females with Meniere's disease (MD).
Methods:
We retrospectively analyzed the serum estradiol (E2) levels and the auditory and vestibular functions measured by auditory brainstem response (ABR) to high click rate, pure-tone audiometry (PTA), and caloric test on postmenopausal women who suffered from MD or not at the Specialist Clinic of Vertigo, Shandong Provincial Hospital, during September 2010 to October 2014.
Results: A total of 76 postmenopausal patients with MD and 50 healthy postmenopausal controls were included. The patients with MD had lower estrogen levels (22.50 ± 16.66 pg/mL vs 30.69 ± 18.59 pg/mL, P = 0.011), longer I-V interpeak latency of ABR (left 0.22 ± 0.16 mseconds vs 0.18 ± 0.10 mseconds, P = 0.118; right 0.24 ± 0.13 mseconds vs 0.17 ± 0.09 mseconds, P = 0.001), and higher unilateral weakness (UW) value (P < 0.001) in comparison with the controls. The mean puretone thresholds of at the speech frequency (500 Hz, 1 kHz, 2 kHz, and 3 kHz) were significantly elevated in patients with MD than those in the controls (left P < 0.001, right P < 0.01). The estradiol level of patients with MD was correlated with ABR latency (left r = −0.229, P < 0.05; right r = −0.220, P < 0.05) and UW value (r = −0.328, P < 0.05), but not with mean pure-tone threshold.
Conclusions:
Estrogen levels correlated with auditory and vestibular function in postmenopausal patients with MD. Low estrogen may be involved in the microcirculatory disturbance of the inner ear, affecting the occurrence and development of MD.
K E Y W O R D S
auditory hearing function, estradiol/blood, Meniere's disease, postmenopausal, vestibular function significant role in treating sudden hearing loss and other hearing impairment disorders. Despite the research of the mechanism and effectiveness of corticosteroid on inner ears has been carried out for years, the systematic cognition is still lacked in clinical treatment. Moreover, the peak of MD is at 40~60 years old, which is the menopausal period of women. Estrogen, 17b-estradiol (E2), is well known as a reproductive steroid hormone, may facilitate the loss of intravascular fluid into the extravascular space, producing edema, given its neuroactive properties. 8, 9 For postmenopausal females, the estrogen levels are sharply reduced because of a permanent loss in ovarian follicles. 10 The role of hormonal factors in causing MD has been controversial, and the contribution of estrogen to MD in females throughout the aging process remains to be elucidated. [11] [12] [13] [14] Moreover, the pathogenetic mechanism of MD is not clear. Therefore, our current study aims to investigate the relationship between estrogen levels and the auditory-vestibular functions in postmenopausal females with MD.
| PATIENTS AND ME THODS

| Ethics statement
The use of human clinical materials in this study was approved by the Ethical Committee of the Shandong Provincial Hospital. All patients or their caregivers have provided written informed consent.
| Patients
Postmenopausal 
| Estrogen measurement
Overnight fasting venous blood samples were obtained between 8:00 and 9:00 a.m. after the subjects had rested for 20-30 minutes. The blood samples were placed in tubes without anticoagulant and then centrifuged at 100.71g for 15 minutes to separate serum from blood. A USA Beckman Coulter ACCESS Automated Chemiluminescent Immunoassay System was used to measure the serum E2 level.
| ABR protocol
All subjects were tested with a USA IHS intelligent EP tester for high stimulus rate auditory brainstem response (ABR). All of the ABR mentioned in the study belongs to high stimulation rate.
High stimulus rate ABR test was recorded using the Intelligent Hearing Systems (IHS) Smart EP system. Electrodes were placed on the vertex (Cz; positive electrode), on both mastoids (Ai and Ac; negative electrodes), and on the forehead (ground).
The responses were filtered with a bandpass of 100-2500 Hz.
The analysis time was 15 mseconds. The stimuli consisted of 100-mseconds alternating clicks presented monaurally at rates of 11.1/s and 51.1/s. 90 dB nHL intensity levels were used, summing to 2000. Each ear was tested separately. All the responses were replicated. The difference of I-V interval between low stimulation rates (11.1/s) and high stimulation rates (51.1/s) was analyzed. The difference over 0.28 mseconds is considered to be abnormal.
| Caloric reflex test
Caloric test was performed with a French Synapsys Ulmer VNG electronystagmography system with a temperature switch irri- of nystagmus after each irrigation was calculated, and unilateral weakness (UW) was determined according to Jongkee's formula.
In our laboratory, the value of UW <25% was considered to be normal.
| Hearing (Pure-tone average)
Hearing status was obtained with air conduction pure-tone audiometry using postmenopause. The thresholds at frequencies 500 Hz, 1 kHz, 2 kHz, and 3 kHz were carried out in a sound-attenuated testing room. Higher values indicate poorer hearing. 
| Statistical analysis
| RE SULTS
A total of 76 postmenopausal patients with MD (average age 51.6 ± 7.0 years) and 50 postmenopausal healthy subjects (average age 52.0 ± 7.6 years) were included in the study. There was no significant difference in average age between patients with MD and normal subjects. The age of menopause in 76 patients was ranged from 42 to 54 years old with a mean age of 48 years. 
| D ISCUSS I ON
Previous studies have reported that decline in estrogen is partly associated with the onset of postmenopausal symptoms and diseases. [15] [16] [17] [18] [19] In this study, we studied the correlation between Estradiol (pg/mL), median (25%-75%) Epidemiological studies have revealed that estrogen regulates vascular endothelial tone, cerebral blood flow, neurotransmitter system, as well as neuroactive metabolites. 18, [22] [23] [24] Estrogen also has a sodium-water retention function to maintain the ionic and liquid balance of the endolymphatic lymph nodes. 25 Besides that, estrogen could enhance GABA inhibition through GABA A synaptic receptors, receptors in brainstem vestibular nucleus, regulating the eyeball movement, vestibular ocular reflex, and vestibular spinal reflex. 26 It was also reported that the risks of postural instability and falling could be reduced by hormone replacement therapy in postmenopausal women. 27 In the present study, most of the postmenopausal females with MD had abnormal auditory brainstem response (69.74%) and unilateral vestibular hypofunction (67.1%).
Furthermore, estrogen levels of the postmenopausal females with MD were associated with elevated I-V interpeak latency (worse) and greater unilateral weakness (worse) than the controls. However, we reckoned that such correlation is rather weak (left r = −0.229, right r = −0.220; −0.328, respectively) although the results were statistically significant. And there was no relationship between estrogen levels and higher pure-tone thresholds in ears. Such results, however, may be associated with our limited number of cases, lack of large sample studies, or the effects of estrogen on the hearing system of animals or humans, which need to be further explored.
The physiological functions of estrogen are mediated through estrogen receptors, the ERα and ERβ. 9, 19 Both of these receptors are found in the inner ear, with ERα-specific localization in the spiral ganglion type I cells and ERβ in the stria vascularis involved in the ion and fluid balance of the endolymph and cochlear and vestibular sensory transduction. 8, 9 Furthermore, expressions of estrogen receptors in the inner ear seem to be modulated by circulating levels of estrogen. 28 Previous animal studies reported that ERβ knockout mice had severe progressive hearing loss and the female midshipman fish had ERα expression in the inner ear, the auditory mechanism of which could be changed by the estrogen level. 29, 30 These contradict a recent study that reported no significant difference in the allelic frequency of ERα polymorphisms between patients with MD and controls (no MD and SSNHLX). 13 Also in this study, the polymorphisms of ERα entailed no significant risk of MD. The underlying reasons for such discrepancies and estrogen effect in Meniere's disease remain to be elucidated. 
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